" A medical play developing CBD-based treatments for cardiovascular diseases

It can be hard to wrap your head around the number of diseases and conditions that people live with every day, but almost
The Market Herald Video

" Cardiol Therapeutics (TSX:CRDL) receives clearance to expedite enrollment in the LANCER trial

Cardiol Therapeutics (CRDL) has received clearance to modify the inclusion criteria for the LANCER trial.
The Market Herald Video

" Cardiol Therapeutics (TSX:CRDL) closes US$50M public offering

Cardiol Therapeutics (CRDL) has announced the closing of its US$50M public offering.

" Cardiol Therapeutics (TSX:CRDL) expands phase II/III trial of CardiolRx

Cardiol Therapeutics (CRDL) is expanding its LANCER trial to include several hospital centers in Brazil, Mexico, and Canada.

" Cardiol Therapeutics (TSX:CRDL) welcomes Michael J. Willner to the board

Cardiol Therapeutics  (CRDL) is pleased to announce the appointment of Michael J. Willner, Esq. to its Board of Directors, effective immediately.